Page last updated: 2024-12-05
tebuthiuron
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5383 |
CHEMBL ID | 1457493 |
CHEBI ID | 81745 |
SCHEMBL ID | 66366 |
MeSH ID | M0055755 |
Synonyms (104)
Synonym |
---|
BRD-K34820100-001-02-1 |
tebuthiuron |
urea, n-[5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl]-n,n'-dimethyl- |
KBIO1_001466 |
DIVK1C_006522 |
SPECTRUM_001825 |
BSPBIO_002345 |
SPECTRUM5_001958 |
NCGC00023459-03 |
NCGC00023459-02 |
NCGC00023459-04 |
n-(5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl)-n,n'-dimethylurea |
urea, 2-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethyl- |
tebuthiuron [ansi:bsi:iso] |
tebulan |
el-103 |
urea, 1-(5-(t-butyl)-1,3,4-thiadiazol-2-yl)-1,3-dimethyl- |
sha 105501 |
prefmid |
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-3-dimethylharnstoff [german] |
caswell no. 366aa |
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea |
brn 0527479 |
einecs 251-793-7 |
graslan |
perflan |
tiurolan |
spike |
graslan 250 brush bullets |
urea, n-(5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl)-n,n'-dimethyl- |
brush bullet |
brulan |
n-(5-(1,1-dimethylaethyl)-1,3,4-thiadiazol-2-yl)-n,n'-dimethylharnstoff [german] |
epa pesticide chemical code 105501 |
spike 80w |
hsdb 6863 |
smr000036753 |
MLS000079345 |
KBIOGR_001065 |
KBIO3_001845 |
KBIO2_002327 |
KBIOSS_002330 |
KBIO2_007463 |
KBIO2_004895 |
SPECTRUM3_000823 |
SPBIO_001782 |
SPECPLUS_000426 |
SPECTRUM4_000663 |
SPECTRUM2_001881 |
SPECTRUM330031 |
34014-18-1 |
n-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-n,n'-dimethylurea |
NCGC00020997-01 |
NCGC00023459-05 |
AKOS005467953 |
NCGC00020997-08 |
NCGC00020997-03 |
NCGC00020997-02 |
NCGC00020997-05 |
NCGC00020997-07 |
NCGC00020997-06 |
NCGC00020997-04 |
STK537090 |
C18436 |
tox21_300802 |
dtxcid704316 |
cas-34014-18-1 |
dtxsid3024316 , |
NCGC00254706-01 |
tox21_201451 |
NCGC00259002-01 |
chebi:81745 , |
CHEMBL1457493 |
1-(5-(tert-butyl)-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea |
A822041 |
CCG-39419 |
HMS2451L04 |
n-[5-(tert-butyl)(1,3,4-thiadiazol-2-yl)]-n-methyl(methylamino)carboxamide |
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-3-dimethylharnstoff |
n-(5-(1,1-dimethylaethyl)-1,3,4-thiadiazol-2-yl)-n,n'-dimethylharnstoff |
e5ox6gm11e , |
unii-e5ox6gm11e |
FT-0630577 |
tebuthiuron [mi] |
tebuthiuron [hsdb] |
tebuthiuron [iso] |
SCHEMBL66366 |
T3647 |
n-[5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl]-nn'-dimethylurea |
urea, 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethyl- |
perfmid |
bushwacker |
preflan |
HBPDKDSFLXWOAE-UHFFFAOYSA-N |
el 103 |
tebuthiuron, pestanal(r), analytical standard |
tebuthiuron 10 microg/ml in acetonitrile |
J-019419 |
mfcd00078732 |
1-[5-(tert-butyl)-1,3,4-thiadiazol-2-yl]-1,3-dimethylurea |
Q125986 |
T72327 |
BS-44188 |
CS-0320310 |
Research Excerpts
Overview
Tebuthiuron (TBU) is a phenylurea herbicide that is extensively used in sugarcane fields.
Excerpt | Reference | Relevance |
---|---|---|
"Tebuthiuron (TBU) is a phenylurea herbicide that is extensively used in sugarcane fields. " | ( Influence of temperature on biomarker responses and histology of the liver of American bullfrog tadpoles (Lithobates catesbeianus, Shaw, 1802) exposed to the herbicide Tebuthiuron. Abel, G; Alves, TC; Bainy, ACD; Bitschinski, D; da Silva, EB; da Silva, SP; de Albuquerque, CAC; de Almeida, EA; Grott, SC; Israel, NG; Lima, D; Mattos, JJ, 2021) | 2.26 |
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
" However, the potential toxic effects of TBU on aquatic developing organisms have been poorly studied." | ( Integrating morphological, biochemical, behavioural, and molecular approaches to investigate developmental toxicity triggered by tebuthiuron in zebrafish (Danio rerio). da Silva Ferreira, ME; de Oliveira, AÁS; Dorta, DJ; Dreossi, SC; Gravato, C; Oliveira, DP; Vieira, LC, 2023) | 1.12 |
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
"Orally dosed tebuthiuron was readily absorbed in mice, rats, rabbits, dogs, and ducks." | ( Metabolism of a new herbicide, tebuthiuron (1-[5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl]- 1,3-dimethylurea), in mouse, rat, rabbit, dog, duck, and fish. Hoffman, DG; Morton, DM, 1976) | 0.91 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (2)
Class | Description |
---|---|
organonitrogen heterocyclic compound | Any organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms. |
organosulfur heterocyclic compound | |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein Targets (31)
Potency Measurements
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 707.9460 | 0.0032 | 45.4673 | 12,589.2998 | AID2517 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 61.1306 | 0.0060 | 38.0041 | 19,952.5996 | AID1159523 |
AR protein | Homo sapiens (human) | Potency | 54.4827 | 0.0002 | 21.2231 | 8,912.5098 | AID743042 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 48.7458 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224893 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 35.5703 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552; AID1159555 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 27.2993 | 0.0008 | 17.5051 | 59.3239 | AID1159527; AID1159531 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 86.4370 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 64.6456 | 0.0054 | 28.0263 | 1,258.9301 | AID1346982; AID720659 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 46.0619 | 0.0002 | 29.3054 | 16,493.5996 | AID743075; AID743079; AID743080 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 1.9494 | 0.0237 | 23.2282 | 63.5986 | AID743223 |
aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 76.9588 | 0.0007 | 23.0674 | 1,258.9301 | AID743085; AID743122 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 76.9588 | 0.0016 | 28.0151 | 77.1139 | AID1224843 |
histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 29.9231 | 0.0376 | 17.0823 | 61.1927 | AID1259364; AID1259388 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 76.9588 | 0.0006 | 27.2152 | 1,122.0200 | AID720636 |
cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 12.5893 | 0.0316 | 10.2792 | 39.8107 | AID884; AID885 |
Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 12.5893 | 1.0000 | 12.2248 | 31.6228 | AID885 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Ceullar Components (1)
Process | via Protein(s) | Taxonomy |
---|---|---|
plasma membrane | Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) |
plasma membrane | Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) |
plasma membrane | Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Bioassays (17)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5 | Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1 | High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7 | A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
AID977599 | Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6 | Structure-based identification of OATP1B1/3 inhibitors. |
AID977602 | Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM | 2013 | Molecular pharmacology, Jun, Volume: 83, Issue:6 | Structure-based identification of OATP1B1/3 inhibitors. |
AID1159550 | Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening | 2015 | Nature cell biology, Nov, Volume: 17, Issue:11 | 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (35)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (8.57) | 18.7374 |
1990's | 1 (2.86) | 18.2507 |
2000's | 8 (22.86) | 29.6817 |
2010's | 14 (40.00) | 24.3611 |
2020's | 9 (25.71) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.83
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (32.83) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (2.78%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 35 (97.22%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |